Aerocrine AB clinical trials
Acquired by NIOX Group plc, Jun 15, 2015 · source ↗
The registry lists 7 studies whose lead sponsor is Aerocrine AB. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 15, 2017.
- 7studies on the registry
- 0open to participants now
Before and after it joined NIOX Group plc
- First submitted before Aerocrine AB became part of NIOX Group plc
- 5
- First submitted after Aerocrine AB became part of NIOX Group plc
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 7 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed686%
- Status unknown or other114%
Over the years
- 11
- 312
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 1 started before 2011. 2026 so far in the lighter column.
Registry sponsor names on this page
- Aerocrine AB7 studies
Something wrong with this grouping? Tell us on the NIOX Group plc page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All NIOX Group plc studies →
- Measurement of FeNO in Young Children With the NIOX VEROStatus unknownNCT02661984
Sponsor listed in the registry: Aerocrine AB · First submitted after Aerocrine AB became part of NIOX Group plc
- NIOX VERO Nasal Application in Primary Ciliary DyskinesiaCompletedNCT02622061
Sponsor listed in the registry: Aerocrine AB · First submitted after Aerocrine AB became part of NIOX Group plc
- A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed AsthmaCompletedNCT01648920
Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc
- Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of AgeCompletedNCT01729247
Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc
- Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways DiseaseCompletedNCT01634620
Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc
- Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory SymptomsCompletedNCT01518322
Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc
- Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory TreatmentCompletedNCT00388570Not applicable
Sponsor listed in the registry: Aerocrine AB · First submitted before Aerocrine AB became part of NIOX Group plc